Salix Pharmaceuticals, Inc. drugs

4 results

  • moviprep

    (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE)
    Salix Pharmaceuticals, Inc.
    MoviPrep® is an osmotic laxative indicated for colonic cleansing prior to colonoscopy in adults.
    Medication Details
    Drug Interactions

  • relistor

    (Methylnaltrexone bromide)
    Salix Pharmaceuticals, Inc.
    RELISTOR is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain or advanced illness requiring opioid escalation for palliative care, including those with chronic pain related to prior cancer or its treatment.
    Medication Details
    Drug Interactions

  • uceris

    (budesonide)
    Salix Pharmaceuticals, Inc.
    UCERIS rectal foam is indicated for inducing remission in patients with active mild to moderate distal ulcerative colitis, specifically when it extends up to 40 cm from the anal verge.
    Medication Details
    Drug Interactions

  • xifaxan

    (rifaximin)
    Salix Pharmaceuticals, Inc.
    XIFAXAN is indicated for treating travelers’ diarrhea caused by noninvasive E. coli in patients aged 12 and older, reducing hepatic encephalopathy recurrence in adults, and managing irritable bowel syndrome with diarrhea in adults. It should only be used for infections due to susceptible bacteria to prevent resistance.
    Medication Details
    Drug Interactions